NanoViricides
NNVC
#10132
Rank
โ‚น1.98 B
Marketcap
โ‚น110.50
Share price
0.82%
Change (1 day)
-10.63%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: โ‚น1.98 Billion

As of December 2025 NanoViricides has a market cap of โ‚น1.98 Billion. This makes NanoViricides the world's 10132th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.98 B7.72%
2024โ‚น1.84 B85.1%
2023โ‚น0.99 B-6.47%
2022โ‚น1.06 B-66.58%
2021โ‚น3.19 B42.55%
2020โ‚น2.23 B223.11%
2019โ‚น0.69 B-28.72%
2018โ‚น0.97 B-72.69%
2017โ‚น3.55 B-15.9%
2016โ‚น4.23 B-6.67%
2015โ‚น4.53 B-53.5%
2014โ‚น9.75 B-34.29%
2013โ‚น14.83 B262.22%
2012โ‚น4.09 B-14.99%
2011โ‚น4.81 B-47.29%
2010โ‚น9.14 B75.73%
2009โ‚น5.20 B8.9%
2008โ‚น4.77 B161.96%
2007โ‚น1.82 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of NanoViricides was reported to be:

โ‚น2.02 Billion
by Nasdaq info icon info icon
โ‚น1.98 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚น143.56 B 7,119.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น100.87 B 4,972.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น13.512 T 679,374.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 479,494.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น22.376 T 1,125,105.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.778 T 441,340.07%๐Ÿ‡ฌ๐Ÿ‡ง UK